Biocytogen and Janssen Sign Licensing Agreement for RenLite Platform
Biocytogen Pharmaceuticals (Beijing) Co., Ltd (HKG: 2315) has announced the signing of a non-exclusive licensing...
Deals
AmVision Biotech Secures RMB 100 Million in Series A+ Financing for Ophthalmology Innovation
AmVision Biotech, an ophthalmology device platform company based in Guangzhou, has reportedly raised close to...
Evaheart Med Raises USD 100 Million in Series A Funding Led by Sinovac
Chongqing Evaheart Medical Device Co., Ltd has reportedly raised close to USD 100 million in...
HQ Pharma and Shanxi HCXF Partner to Expand Oral Soluble Film R&D and Production
China-based firms HQ Pharma and Shanxi HCXF Pharmaceutical Co., Ltd have agreed to jointly expand...
Biocytogen and Janssen Sign Licensing Agreement for RenLite Platform
Biocytogen Pharmaceuticals (Beijing) Co., Ltd (HKG: 2315) has announced the signing of a non-exclusive licensing...
Sumitomo Pharma Secures Rights to Vibegron for Asian Markets
Japan-based Sumitomo Pharma Co., Ltd has signed a sub-license deal with compatriot firm Kyorin Pharmaceutical...
Suzhou Porton Biologics Partners with Bennu Biotherapeutics for Gene and Cell Therapies
China-based contract development and manufacturing organization (CDMO) Suzhou Porton Biologics Ltd has entered into a...
Akeso Biopharma and Shanghai Pharmaceuticals Collaborate on Liposarcoma Treatment
China-based Akeso Biopharma (HKG: 9926) has announced a strategic collaboration agreement with compatriot firm Shanghai...
F-star Therapeutics’ Acquisition by invoX Pharma Cleared by CFIUS
UK biotech F-star Therapeutics, Inc. (NASDAQ: FSTX) has announced that it has received clearance from...
Heranova Closes $10M Seed Round for Women’s Health Solutions
Heranova Lifesciences Holding, a provider of women’s health solutions, has announced the successful closure of...
Abcam and MEDx Expand Strategic Partnership on Claudin 18.2 Diagnosis
UK-based abcam (NASDAQ:ABCM) has announced a licensing agreement with China-headquartered MEDx Translational Medicine Co., Ltd,...
Neo Modulus Secures Series B Funding for Regenerative Medical Device Development
Neo Modulus, a developer of regenerative implantable medical devices based in Suzhou, has reportedly raised...
QL Biopharm Raises Series B Funding for Protein Drug Development
QL Biopharm, a Beijing-based developer of Escherichia coli-based protein drugs, has reportedly raised RMB 100...
Siyi Intelligence Raises Series A Funding for Neural Rehabilitation Solutions
Siyi Intelligence, a developer of soft rehabilitation robots based in Shanghai, has reportedly raised close...
PulseCare Raises Pre-Series A Funding for Minimally Invasive Treatment Devices
PulseCare, a Shenzhen-based maker of minimally and non-invasive treatment devices, has reportedly raised “tens of...
HKUST and PhIRDA Sign MoU to Establish Innovation Centers
The Hong Kong University of Science and Technology (HKUST) and the China Pharmaceutical Innovation and...
ClinChoice Acquires Cromsource to Expand Global CRO Footprint
Sino-US Contract Research Organization (CRO) ClinChoice Medical Development has announced the acquisition of Cromsource S.r.l.,...
Echo Biotech Secures Series A++ Funding for Exosomes Drug Development
Echo Biotech, a Beijing-based exosomes drug developer, has reportedly raised “tens of millions” of renminbi...
TinKer Bio Raises Series A+ Funding for Microfluidic Chip Expansion
China-based Hangzhou TinKer BioTechnology Co., Ltd, a leading microfluidic chip technology platform company, has reportedly...
Hexin Medical Technology Raises Series A Funding for Radionuclide Therapy
Hexin Medical Technology Co., Ltd, a radionuclide therapy developer based in Suzhou, has reportedly raised...